Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 11, 2026
Strive (ASST): Can It Reach $30? +141% Upside Hinges on Bitcoin

Strive (ASST): Can It Reach $30? +141% Upside Hinges on Bitcoin

Key Takeaways

  • Price Target in Focus: The $30 level sits squarely within the Wall Street consensus, with analyst targets ranging from $20 to $38 and the average hovering near $28–$29.
  • Bitcoin Treasury Model: Strive holds approximately 13,741 Bitcoin, making its stock price heavily dependent on Bitcoin's performance and the company's ability to accumulate additional coins at favorable prices.
  • Capital Structure Innovation: The SATA perpetual preferred stock (ticker: SATA) with a 13% annualized daily dividend has provided a non-dilutive funding mechanism, supporting continued Bitcoin purchases.
  • Extreme Volatility: With a beta of 13.19 and a 52-week range spanning $7.02 to $252.00, ASST remains one of the most volatile equities on Nasdaq, amplifying both upside and downside risk.
  • Key Takeaway: Reaching $30 is mathematically feasible if Bitcoin sustains a meaningful rally, but the path requires continued capital formation, stable or rising Bitcoin prices, and favorable market sentiment toward the Bitcoin treasury model.

Why the $30 Level Stands Out

$30 represents a natural psychological threshold — a round number that aligns closely with the consensus analyst price target. ASST briefly touched levels above $250 during its post-merger euphoria phase in 2025 before a dramatic correction brought shares back into single digits. The $30 target, therefore, sits in a realistic middle ground: far enough above the current $12.44 price to offer meaningful upside, yet well below the speculative frenzy levels seen during the initial Bitcoin treasury re-rating.

Multiple Wall Street firms have converged on this zone. TD Cowen, which initially set a $28 target, raised it to $30 in May 2026 before trimming back to $28 in July — maintaining a Buy rating throughout. Benchmark initiated coverage with a $32 target, while Maxim Group raised its target from $20 to $28. HC Wainwright remains the most bullish at $38. This clustering around $28–$30 signals a strong conviction among analysts that Strive's Bitcoin-centric business model supports a substantial re-rating if execution remains on track.

Strive's Bitcoin Treasury Approach

Strive, Inc. operates a dual business model. Its wholly owned subsidiary, Strive Asset Management, LLC, is an SEC-registered investment adviser managing over $2 billion in exchange-traded funds (ETFs). However, the primary driver of the stock's valuation is its Bitcoin treasury strategy — modeled after MSTR (MicroStrategy) but with its own capital structure innovations.

The company discloses its Bitcoin holdings publicly: as of mid-2026, Strive held roughly 13,741 Bitcoin alongside approximately $86.9 million in cash and cash equivalents, with zero debt on its balance sheet. The company generates a Bitcoin yield — a measure of Bitcoin per share growth — that reached 16.2% year-to-date as of May 2026, reflecting its ability to grow Bitcoin holdings faster than share dilution. I also checked comparable holdings data using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Potential Catalysts for a Move to $30

Bitcoin Price Appreciation: The single largest catalyst for ASST is a sustained rise in Bitcoin. HC Wainwright's $38 target assumes a year-end 2026 Bitcoin price of $150,000 per coin. Should Bitcoin rally toward or beyond that level, Strive's net asset value would expand significantly, potentially driving the stock past $30 even without multiple expansion.

Accretive Capital Formation: The SATA preferred stock — a variable-rate perpetual preferred paying 13% annualized dividends daily — has proven to be an effective capital-raising tool. Combined with the company's at-the-market (ATM) equity program, Strive can continue purchasing Bitcoin without relying on debt. A $500 million Class A common stock repurchase authorization also signals management's willingness to defend shareholder value.

ETF and Asset Management Growth: Strive's asset management subsidiary provides a recurring revenue stream and brand credibility. As the firm's ETF lineup expands and assets under management grow, management fees contribute incremental revenue that supports the broader corporate strategy.

Risks That Could Delay Progress

Bitcoin Correlation Risk: ASST functions as a high-beta proxy for Bitcoin. Any prolonged Bitcoin downturn would directly impair the company's net asset value and likely cause the stock to trade at a discount to its Bitcoin holdings, as the market-to-net-asset-value (NAV) multiple compresses under bearish sentiment.

Share Dilution: The ATM equity program that funds Bitcoin purchases also increases the share count. While management emphasizes Bitcoin-per-share growth, aggressive dilution can erode equity value per share if Bitcoin prices stagnate or decline. The fully diluted share count must be monitored closely.

GAAP Losses: Strive reported a GAAP net loss of $265.9 million in Q1 2026, heavily impacted by merger-related impairment charges. While management highlights non-GAAP adjusted figures that exclude these non-cash items, the headline losses can deter institutional investors and weigh on market sentiment.

Competition: Strive is not the only Bitcoin treasury company. MSTR remains the dominant player with far larger Bitcoin holdings and a longer track record. Other companies are adopting similar treasury strategies, potentially diluting the premium investors assign to the Bitcoin treasury model.

Analyst Views and Valuation Context

Five Wall Street analysts currently cover ASST, and all five rate the stock a Buy or Strong Buy. The average 12-month price target sits at approximately $29, implying roughly 133% upside from the current price. The tight dispersion among targets — ranging from B. Riley's $20 to HC Wainwright's $38 — reflects relatively high conviction despite the stock's inherent volatility.

From a valuation standpoint, traditional metrics offer limited insight. ASST trades at a negative trailing P/E ratio (TTM) due to merger-related impairment charges, and the price-to-sales ratio of approximately 113x reflects minimal current revenue relative to the market capitalization. Analysts instead value the company based on its Bitcoin holdings, applying a market-to-NAV multiple — currently around 1.3x — that compares favorably to MSTR's historical averages.

Technical Levels Worth Monitoring

The $30 level carries technical significance beyond its psychological appeal. The 52-week chart shows ASST consolidating in a range between approximately $7 and $17 after a prolonged decline from its post-merger peak near $252. A move toward $30 would require breaking through multiple resistance zones, including the $15–$17 region that has capped several rally attempts, followed by the psychologically important $20 and $25 levels. The $30 target roughly coincides with the lower end of the analyst range, suggesting it represents a realistic near-to-medium-term objective rather than an aspirational peak.

Support on the downside appears established near $10–$11, where buyers have consistently stepped in during recent months. A break below the 52-week low of $7.02 would signal a significant deterioration in the bullish thesis. From what I see, the patterns here align with broader Bitcoin momentum signals.

Using AI Tools for Timely Insights

Navigating a volatile stock like ASST requires timely information and disciplined decision-making. I've found that integrating AI-generated signals into a broader research process may help traders act more confidently in fast-moving markets.

Overall Assessment

Can Strive (ASST) reach $30? The evidence suggests it is a realistic but conditional objective. The primary engine for such a move — Bitcoin price appreciation — has historically delivered multi-year rallies of the magnitude required. Strive's capital structure, with zero traditional debt and innovative preferred stock financing, positions the company to continue accumulating Bitcoin accretively. Wall Street analysts, who derive their targets from detailed NAV models, uniformly project price targets at or above $30 within a 12-month horizon.

However, the path is far from guaranteed. ASST remains a leveraged bet on Bitcoin, and any sustained weakness in cryptocurrency markets would likely delay or derail the move toward $30. Share dilution, execution risk around capital formation, and broader market sentiment toward high-beta equities all represent variables investors must monitor. The $30 target appears achievable under a favorable Bitcoin scenario, but investors should approach the stock with a clear understanding of its extreme volatility and the macro forces that drive it. I'm watching this closely as Bitcoin trends evolve.

Tickeron AI Daily Buy/Sell Signals in Practice

For stocks with this level of volatility, I rely on tools that provide structured signals. Tickeron's AI Daily Buy/Sell Signals help me stay on top of technical shifts and market conditions without constant manual monitoring. This fits naturally into my routine when evaluating Bitcoin-related names like ASST.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ASST

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


ASST's RSI Indicator stays in overbought zone for 2 days

Watch for a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ASST broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ASST entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on ASST as a result. In of 58 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ASST moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ASST crossed bullishly above the 50-day moving average on August 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in of 146 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.426) is normal, around the industry mean (3.525). P/E Ratio (0.000) is within average values for comparable stocks, (27.186). ASST's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.208). ASST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.086). ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (16.512).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.63B. The market cap for tickers in the group ranges from 57 to 179.11B. BLK holds the highest valuation in this group at 179.11B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 5%. ZSTK experienced the highest price growth at 143%, while AMBR experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 55
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 78
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
ASST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InvestmentManagers

Profile
Details
Industry
N/A
Address
200 Crescent Court
Phone
+1 855 427-7360
Employees
28
Web
https://www.strive.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.